PE20170661A1 - Formas cristalinas de 6-((6,7-dimetoxiquinazolin-4-il)oxi)-n,2-dimetilbenzofuran-3-carboxamida - Google Patents
Formas cristalinas de 6-((6,7-dimetoxiquinazolin-4-il)oxi)-n,2-dimetilbenzofuran-3-carboxamidaInfo
- Publication number
- PE20170661A1 PE20170661A1 PE2017000426A PE2017000426A PE20170661A1 PE 20170661 A1 PE20170661 A1 PE 20170661A1 PE 2017000426 A PE2017000426 A PE 2017000426A PE 2017000426 A PE2017000426 A PE 2017000426A PE 20170661 A1 PE20170661 A1 PE 20170661A1
- Authority
- PE
- Peru
- Prior art keywords
- crystalline forms
- dimethylbenzofuran
- carboxamide
- oxy
- dimetoxyquinazolin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Se refiere a nuevas formas cristalinas del compuesto 6-((6,7-dimetoxiquinazolin-4-il)oxi)-N,2-dimetilbenzofuran-3-carboxamida de formula A, preferentemente las formas cristalinas I, III y VII; cuyos patrones de difraccion de rayos X en polvo (DRXP) en cuanto a 2(theta) son: 5.3°, 10.7°, 13.9° y 14.6° ± 0.2° para la forma I; 7.2°, 8.6°, 14.4° y 15.2° ± 0.2° para la forma III y 9.0°, 11.8° y 13.6°± 0.2° para la forma VII. Tambien se refiere a sus metodos de obtencion y a una composicion farmaceutica. Dichos compuestos son inhibidores de la cinasa KDR, siendo utiles en el tratamiento de trastornos relacionados con la angiogenesis tales como el cancer, degeneracion macular senil y enfermedad inflamatoria cronica
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410456350.9A CN105461702A (zh) | 2014-09-10 | 2014-09-10 | 6-(6,7-二甲氧基喹唑啉-4-基氧基)-n,2-二甲基苯并呋喃-3-甲酰胺晶型 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20170661A1 true PE20170661A1 (es) | 2017-05-18 |
Family
ID=55458346
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2017000426A PE20170661A1 (es) | 2014-09-10 | 2015-09-07 | Formas cristalinas de 6-((6,7-dimetoxiquinazolin-4-il)oxi)-n,2-dimetilbenzofuran-3-carboxamida |
Country Status (31)
| Country | Link |
|---|---|
| US (3) | US10519142B2 (es) |
| EP (1) | EP3191475B1 (es) |
| JP (2) | JP6655608B2 (es) |
| KR (2) | KR102221722B1 (es) |
| CN (3) | CN105461702A (es) |
| AU (1) | AU2015316010B2 (es) |
| BR (1) | BR112017004000B1 (es) |
| CA (1) | CA2958666C (es) |
| CL (1) | CL2017000540A1 (es) |
| CY (1) | CY1123892T1 (es) |
| DK (1) | DK3191475T3 (es) |
| EA (1) | EA034730B1 (es) |
| ES (1) | ES2819242T3 (es) |
| HK (1) | HK1231479A1 (es) |
| HR (1) | HRP20201501T1 (es) |
| HU (1) | HUE050580T2 (es) |
| IL (1) | IL250647B (es) |
| LT (1) | LT3191475T (es) |
| MX (1) | MX370791B (es) |
| MY (1) | MY176618A (es) |
| PE (1) | PE20170661A1 (es) |
| PH (1) | PH12017500451A1 (es) |
| PL (1) | PL3191475T3 (es) |
| PT (1) | PT3191475T (es) |
| RS (1) | RS60829B1 (es) |
| SG (1) | SG11201701544UA (es) |
| SI (1) | SI3191475T1 (es) |
| TW (1) | TWI718105B (es) |
| UA (1) | UA120371C2 (es) |
| WO (1) | WO2016037550A1 (es) |
| ZA (1) | ZA201701320B (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105461702A (zh) * | 2014-09-10 | 2016-04-06 | 和记黄埔医药（上海）有限公司 | 6-(6,7-二甲氧基喹唑啉-4-基氧基)-n,2-二甲基苯并呋喃-3-甲酰胺晶型 |
| CN111164085B (zh) | 2017-09-29 | 2023-04-04 | 杭州领业医药科技有限公司 | 瑞博西林的共晶和瑞博西林单琥珀酸盐的共晶、其制备方法、组合物和用途 |
| US11236077B2 (en) | 2018-03-30 | 2022-02-01 | Hangzhou Solipharma Co., Ltd. | Fruquintinib eutectic crystal, preparation method therefor, composition, and uses thereof |
| CN111184698A (zh) * | 2018-11-15 | 2020-05-22 | 和记黄埔医药（上海）有限公司 | 呋喹替尼制剂及其应用 |
| WO2020196871A1 (ja) | 2019-03-28 | 2020-10-01 | 住友重機械工業株式会社 | ショベル |
| CN113200966B (zh) * | 2021-04-06 | 2022-07-22 | 深圳大学 | 一种呋喹替尼衍生物、药物组合物和用途 |
| GB202211142D0 (en) * | 2022-07-29 | 2022-09-14 | Macfarlan Smith Ltd | Polymorphs, co-crystals and solvates of fruquintinib, processes for the preparation and use thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7829574B2 (en) * | 2008-05-09 | 2010-11-09 | Hutchison Medipharma Enterprises Limited | Substituted quinazoline compounds and their use in treating angiogenesis-related diseases |
| CN101575333B (zh) * | 2008-05-09 | 2011-06-22 | 和记黄埔医药（上海）有限公司 | 一种喹唑啉衍生物及其医药用途 |
| CN105461702A (zh) * | 2014-09-10 | 2016-04-06 | 和记黄埔医药（上海）有限公司 | 6-(6,7-二甲氧基喹唑啉-4-基氧基)-n,2-二甲基苯并呋喃-3-甲酰胺晶型 |
-
2014
- 2014-09-10 CN CN201410456350.9A patent/CN105461702A/zh active Pending
-
2015
- 2015-09-07 BR BR112017004000-0A patent/BR112017004000B1/pt active IP Right Grant
- 2015-09-07 KR KR1020197004333A patent/KR102221722B1/ko active IP Right Grant
- 2015-09-07 RS RS20201083A patent/RS60829B1/sr unknown
- 2015-09-07 EP EP15839519.4A patent/EP3191475B1/en active Active
- 2015-09-07 SI SI201531358T patent/SI3191475T1/sl unknown
- 2015-09-07 LT LTEP15839519.4T patent/LT3191475T/lt unknown
- 2015-09-07 US US15/510,631 patent/US10519142B2/en active Active
- 2015-09-07 PE PE2017000426A patent/PE20170661A1/es unknown
- 2015-09-07 UA UAA201702962A patent/UA120371C2/uk unknown
- 2015-09-07 MX MX2017002913A patent/MX370791B/es active IP Right Grant
- 2015-09-07 CN CN201580047368.6A patent/CN106604919B/zh active Active
- 2015-09-07 JP JP2017513447A patent/JP6655608B2/ja active Active
- 2015-09-07 ES ES15839519T patent/ES2819242T3/es active Active
- 2015-09-07 KR KR1020177006544A patent/KR20170042662A/ko active Application Filing
- 2015-09-07 CN CN201911135376.2A patent/CN111018846B/zh active Active
- 2015-09-07 EA EA201790275A patent/EA034730B1/ru unknown
- 2015-09-07 WO PCT/CN2015/089035 patent/WO2016037550A1/en active Application Filing
- 2015-09-07 AU AU2015316010A patent/AU2015316010B2/en active Active
- 2015-09-07 DK DK15839519.4T patent/DK3191475T3/da active
- 2015-09-07 PL PL15839519T patent/PL3191475T3/pl unknown
- 2015-09-07 PT PT158395194T patent/PT3191475T/pt unknown
- 2015-09-07 MY MYPI2017700610A patent/MY176618A/en unknown
- 2015-09-07 SG SG11201701544UA patent/SG11201701544UA/en unknown
- 2015-09-07 HU HUE15839519A patent/HUE050580T2/hu unknown
- 2015-09-07 CA CA2958666A patent/CA2958666C/en active Active
- 2015-09-10 TW TW104129900A patent/TWI718105B/zh active
-
2017
- 2017-02-16 IL IL250647A patent/IL250647B/en active IP Right Grant
- 2017-02-21 ZA ZA2017/01320A patent/ZA201701320B/en unknown
- 2017-03-07 CL CL2017000540A patent/CL2017000540A1/es unknown
- 2017-03-09 PH PH12017500451A patent/PH12017500451A1/en unknown
- 2017-05-23 HK HK17105224.8A patent/HK1231479A1/zh unknown
-
2018
- 2018-12-03 JP JP2018226597A patent/JP2019065019A/ja not_active Withdrawn
-
2019
- 2019-11-08 US US16/678,760 patent/US11046674B2/en active Active
-
2020
- 2020-09-21 HR HRP20201501TT patent/HRP20201501T1/hr unknown
- 2020-09-25 CY CY20201100909T patent/CY1123892T1/el unknown
-
2021
- 2021-05-20 US US17/303,114 patent/US11958838B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20170661A1 (es) | Formas cristalinas de 6-((6,7-dimetoxiquinazolin-4-il)oxi)-n,2-dimetilbenzofuran-3-carboxamida | |
| DOP2017000149A (es) | Compuestos de triazolopirimidina y usos de los mismos | |
| CO2017001884A2 (es) | Polimorfos de selinexor | |
| DOP2016000271A (es) | Compuestos de heteroarilo o arilo bicíclicos fusionados | |
| CU20160167A7 (es) | Compuestos de pirazolopiridinas y pirazolopirimidinas útiles en el tratamiento de condiciones alérgicas y respiratorias | |
| CO2018011408A2 (es) | Compuestos de pirimidina como inhibidores de la quinasa jak | |
| EA201790595A1 (ru) | Пиримидиноны в качестве ингибиторов фактора xia | |
| PE20171105A1 (es) | Formas solidas de un inhibidor ask1 | |
| UA113470C2 (xx) | Піримідинові та піридинові сполуки та їх застосування | |
| CU24410B1 (es) | Benzimidazol-2-aminas como inhibidores de midh1 | |
| UY35972A (es) | Inhibidores macrocíclicos de fxia que tienen grupos heterocíclicos | |
| EA201790246A1 (ru) | Гетероциклические карбоновые кислоты в качестве активаторов растворимой гуанилатциклазы | |
| MA40076A (fr) | Inhibiteurs de syk | |
| ECSP17046848A (es) | Nuevos compuestos y composiciones farmacéuticas de los mismos para el tratamiento de desórdenes inflamatorios y osteoartritis | |
| NI201500122A (es) | Sal de abexinostato novedosa, forma cristalina relacionada, método de preparación de esta y las composiciones farmacéuticas que la contienen. | |
| GEP20207108B (en) | Substituted 2,4 diamino-quinoline as new anticancer agents | |
| PH12016502394A1 (en) | 1, 3, 4-thiadiazole compounds and their use in treating cancer | |
| CU20160003A7 (es) | Pirazololpiridinaminas sustituidas | |
| UY35746A (es) | Derivados de fenilalanina sustituidos | |
| EA201790830A1 (ru) | Ингибиторы альдостеронсинтазы | |
| DOP2015000299A (es) | Derivados de prodroga de triazolpiridinas sustituidas | |
| UY33019A (es) | Nuevos derivados de 2-aminotiadiazol | |
| AR080363A1 (es) | Cristal molecular de derivado de (4-(1,8-naftiridin -2-il) piperidin-1-il) pirimidina |